<DOC>
	<DOCNO>NCT00002921</DOCNO>
	<brief_summary>RATIONALE : Some tumor need growth factor produce body keep grow . Suramin may interfere growth factor stop tumor grow . PURPOSE : Phase II trial study effectiveness suramin treat patient stage III stage IV adrenocortical cancer .</brief_summary>
	<brief_title>S9427 , Suramin Treating Patients With Stage III Stage IV Adrenocortical Cancer Incurable Surgery</brief_title>
	<detailed_description>OBJECTIVES : I. Assess response patient adrenocortical carcinoma treat suramin . II . Evaluate qualitative quantitative toxic effect therapy . OUTLINE : Patients describe accord stage , performance status , prior radiotherapy , prior surgery , prior mitotane therapy . Patients receive suramin IV 5 day first week , twice week 2 week , weekly total 12 week . Hydrocortisone take PO twice daily . Following 12 week rest , patient receive second course ; stable respond disease continue treatment maximum four course . PROJECTED ACCRUAL : A maximum 40 patient accrued rate 6-7 per year .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Adrenocortical Carcinoma</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Suramin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adrenocortical carcinoma Stage III IV incurable surgery Bidimensionally measurable disease PATIENT CHARACTERISTICS : Age : 18 Performance status : SWOG 02 Hematopoietic : WBC least 4,000/mm3 Absolute granulocyte count least 2,000/mm3 Platelet count least 150,000/mm3 Prothrombin time partial thromboplastin time great upper limit normal ( ULN ) Hepatic : SGOT alkaline phosphatase great 2 time ULN Renal : Creatinine clearance least 50 mL/min Serum creatinine great ULN Other : No second malignancy within 5 year except adequately treat basal cell squamous cell carcinoma skin , situ carcinoma cervix , cancer patient disease free 5 year Not pregnant nursing Effective contraception require fertile patient PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent biologic therapy At least 4 week since prior biologic therapy ( one regimen ) Chemotherapy : No concurrent chemotherapy At least 4 week since prior mitotane No prior chemotherapy allow Endocrine therapy : At least 6 week since prior hormonal therapy No concurrent hormonal therapy Radiotherapy : At least 4 week since prior radiation therapy ( le 25 % bone marrow ) No concurrent radiation therapy Surgery : Prior surgery allow relapsed patient prior treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>stage III adrenocortical carcinoma</keyword>
	<keyword>stage IV adrenocortical carcinoma</keyword>
</DOC>